Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bladder Cancer

  Free Subscription


01.11.2021

1 ACS Appl Mater Interfaces
4 Actas Urol Esp (Engl Ed)
1 Am J Case Rep
1 Appl Immunohistochem Mol Morphol
2 Asian Pac J Cancer Prev
1 Biomarkers
1 Biosci Rep
1 BJU Int
1 BMC Cancer
1 BMC Genomics
1 BMJ Case Rep
1 Bull Cancer
1 Can Urol Assoc J
1 Cancer Gene Ther
2 Cancer Manag Res
1 Cancer Res
2 Cancers (Basel)
1 Cells
1 Clin Neuropharmacol
1 Clin Transl Med
1 Comput Biol Med
2 Curr Oncol
1 Curr Opin Support Palliat Care
1 Curr Opin Urol
1 Diagn Cytopathol
1 Diagnostics (Basel)
3 ESMO Open
1 Ethiop J Health Sci
1 Eur Urol Focus
2 Front Endocrinol (Lausanne)
1 Front Genet
1 Front Immunol
4 Front Oncol
1 Future Oncol
1 Gene
1 In Vivo
1 Int J Clin Oncol
1 Int J Mol Sci
7 Int J Radiat Oncol Biol Phys
1 J Bras Pneumol
1 J Cell Mol Med
7 J Endourol
1 J Immunol Res
1 J Pain Palliat Care Pharmacother
1 J Pathol Clin Res
1 J Robot Surg
7 J Urol
1 Kaohsiung J Med Sci
1 Libyan J Med
1 Lipids Health Dis
1 Medicina (Kaunas)
1 Minerva Surg
1 Mol Biol Rep
1 Mol Clin Oncol
1 Mol Ther Nucleic Acids
1 Nat Commun
1 PeerJ
1 Pol J Pathol
1 S Afr J Surg
1 Scand J Urol
1 Sci Rep
1 Semin Diagn Pathol
1 Surg Pathol Clin
1 Urol Int
1 Urologe A
2 Vet Pathol
1 Zentralbl Chir
2 Zhonghua Zhong Liu Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Appl Mater Interfaces

  1. QI A, Wang C, Ni S, Meng Y, et al
    Intravesical Mucoadhesive Hydrogel Induces Chemoresistant Bladder Cancer Ferroptosis through Delivering Iron Oxide Nanoparticles in a Three-Tier Strategy.
    ACS Appl Mater Interfaces. 2021 Oct 29. doi: 10.1021/acsami.1c14944.
    PubMed         Abstract available


    Actas Urol Esp (Engl Ed)

  2. PINTO A, Alvarez-Maestro M
    Adjuvant immunotherapy in muscle-invasive bladder cancer: Closer than it seems?
    Actas Urol Esp (Engl Ed). 2021 Oct 21. pii: S2173-5786(21)00107.
    PubMed        

  3. RODRIGUEZ-SERRANO A, Carrion DM, Gomez Rivas J, Alvarez-Maestro M, et al
    Prognostic value of urinary cytology for detecting urothelial carcinoma recurrence after radical cystectomy.
    Actas Urol Esp (Engl Ed). 2021;45:466-472.
    PubMed         Abstract available

  4. PISANO F, Gontero P, Sylvester R, Joniau S, et al
    Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
    Actas Urol Esp (Engl Ed). 2021;45:473-478.
    PubMed         Abstract available

  5. DOMINGUEZ A, Munoz-Rodriguez J, Martos R, Parejo V, et al
    Progressive perioperative benefits of laparoscopy in combination with an ERAS (Enhanced Recovery After Surgery) protocol in radical cystectomy with ileal conduit.
    Actas Urol Esp (Engl Ed). 2021;45:289-299.
    PubMed         Abstract available


    Am J Case Rep

  6. TAKAHASHI K, Kikuchi A, Horiuchi A, Tamura R, et al
    Vulvar Extramammary Paget Disease Detected by Cytology for Cervical Cancer Screening: A Case Report and Literature Review.
    Am J Case Rep. 2021;22:e933655.
    PubMed         Abstract available


    Appl Immunohistochem Mol Morphol

  7. LOMBARDO KA, Murati Amador B, Parimi V, Hoffman-Censits J, et al
    Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome.
    Appl Immunohistochem Mol Morphol. 2021;29:127-135.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  8. ABDOLAHINIA Z, Pakmanesh H, Mirzaee M, Bazrafshan A, et al
    Opium and Cigarette Smoking are Independently Associated with Bladder Cancer: The Findings of a Matched Case - Control Study.
    Asian Pac J Cancer Prev. 2021;22:3385-3391.
    PubMed         Abstract available

  9. DEMIRCI A, Ozgur BC
    A Google Trends Analysis of Bladder Cancer: Determining Awareness Campaign Success, and Patients' Needs in Clinical Management.
    Asian Pac J Cancer Prev. 2021;22:3115-3120.
    PubMed         Abstract available


    Biomarkers

  10. GRUBA N, Rachubik P, Piwkowska A, Lesner A, et al
    Analysis of urinary kallikrein-related peptidase 13 for monitoring bladder cancer.
    Biomarkers. 2021 Oct 27:1-30. doi: 10.1080/1354750X.2021.1999502.
    PubMed         Abstract available


    Biosci Rep


  11. Correction: Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating beta-catenin.
    Biosci Rep. 2021;41.
    PubMed        


    BJU Int

  12. WETTSTEIN MS, Baxter NN, Sutradhar R, Mamdani M, et al
    Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness study.
    BJU Int. 2021 Oct 21. doi: 10.1111/bju.15622.
    PubMed         Abstract available


    BMC Cancer

  13. ZHEN H, Du P, Yi Q, Tang X, et al
    LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA.
    BMC Cancer. 2021;21:1145.
    PubMed         Abstract available


    BMC Genomics

  14. SHIVAKUMAR M, Han S, Lee Y, Kim D, et al
    Epigenetic interplay between methylation and miRNA in bladder cancer: focus on isoform expression.
    BMC Genomics. 2021;22.
    PubMed         Abstract available


    BMJ Case Rep

  15. DEBNATH A, Cheriyan A, Gopinathan VR, Kumar S, et al
    Adult cystic nephroma masquerading urothelial carcinoma of a calyceal diverticulum.
    BMJ Case Rep. 2021;14.
    PubMed         Abstract available


    Bull Cancer

  16. VEYRI M, Lavole A, Choquet S, Costagliola D, et al
    Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network.
    Bull Cancer. 2021;108:908-914.
    PubMed         Abstract available


    Can Urol Assoc J

  17. PARMAR A, Qazi AA, Stundzia A, Sim HW, et al
    Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Can Urol Assoc J. 2021 Oct 18. pii: cuaj.7294. doi: 10.5489/cuaj.7294.
    PubMed         Abstract available


    Cancer Gene Ther

  18. HUANG Y, Zhu Y, Zhang Z, Li Z, et al
    Correction: UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53.
    Cancer Gene Ther. 2021 Oct 20. pii: 10.1038/s41417-021-00394.
    PubMed        


    Cancer Manag Res

  19. WITJES JA, Feikema AAH
    Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer.
    Cancer Manag Res. 2021;13:7833-7839.
    PubMed         Abstract available

  20. YANG L, Sun HF, Guo LQ, Cao HB, et al
    MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer.
    Cancer Manag Res. 2021;13:7841-7850.
    PubMed         Abstract available


    Cancer Res

  21. WEI W, Sun J, Zhang H, Xiao X, et al
    Circ0008399 interaction with WTAP promotes assembly and activity of the m6A methyltransferase complex and promotes cisplatin resistance in bladder cancer.
    Cancer Res. 2021 Oct 26. pii: 0008-5472.CAN-21-1518.
    PubMed         Abstract available


    Cancers (Basel)

  22. MUDRA SE, Sadhukhan P, Ugurlu MT, Alam S, et al
    Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available

  23. SHIMURA S, Matsumoto K, Shimizu Y, Mochizuki K, et al
    Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available


    Cells

  24. ABIDINE Y, Giannetti A, Revilloud J, Laurent VM, et al
    Viscoelastic Properties in Cancer: From Cells to Spheroids.
    Cells. 2021;10.
    PubMed         Abstract available


    Clin Neuropharmacol

  25. BILIC H, Sitas B, Hancevic M, Habek M, et al
    Severe Demyelinating Polyneuropathy and Cranial Neuropathy During Avelumab Treatment of Metastatic Merkel Cell Carcinoma.
    Clin Neuropharmacol. 2021;44:193-195.
    PubMed         Abstract available


    Clin Transl Med

  26. XU W, Anwaier A, Liu W, Tian X, et al
    Adenylate cyclase-activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer.
    Clin Transl Med. 2021;11:e597.
    PubMed        


    Comput Biol Med

  27. GARCIA G, Esteve A, Colomer A, Ramos D, et al
    A novel self-learning framework for bladder cancer grading using histopathological images.
    Comput Biol Med. 2021;138:104932.
    PubMed         Abstract available


    Curr Oncol

  28. BEIGI A, Vafaei-Nodeh S, Huang L, Sun SZ, et al
    Survival Outcomes Associated with First and Second-Line Palliative Systemic Therapies in Patients with Metastatic Bladder Cancer.
    Curr Oncol. 2021;28:3812-3824.
    PubMed         Abstract available

  29. NARITA S, Saito M, Numakura K, Habuchi T, et al
    Incidence, Etiology, Prevention and Management of Ureteroenteric Strictures after Robot-Assisted Radical Cystectomy: A Review of Published Evidence and Personal Experience.
    Curr Oncol. 2021;28:4109-4117.
    PubMed         Abstract available


    Curr Opin Support Palliat Care

  30. LOKESHWAR SD, Press BH, Nie J, Klaassen Z, et al
    Cachexia and bladder cancer: clinical impact and management.
    Curr Opin Support Palliat Care. 2021 Oct 25. pii: 01263393-900000000-99277.
    PubMed         Abstract available


    Curr Opin Urol

  31. CICIONE A, Lombardo R, D'Annunzio S, De Nunzio C, et al
    Success factors for abdominal wall diversions, including ureterocutaneostomy.
    Curr Opin Urol. 2021;31:544-549.
    PubMed         Abstract available


    Diagn Cytopathol

  32. NODIT PG, Sneed G, Hubbard EW
    Abundant small blue cells: Challenges in urine cytology interpretation.
    Diagn Cytopathol. 2021;49:546-548.
    PubMed        


    Diagnostics (Basel)

  33. DZUBINSKA D, Zvarik M, Kollarik B, Sikurova L, et al
    Multiple Chromatographic Analysis of Urine in the Detection of Bladder Cancer.
    Diagnostics (Basel). 2021;11.
    PubMed         Abstract available


    ESMO Open

  34. FORNARINI G, Rebuzzi SE, Banna GL, Calabro F, et al
    Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort.
    ESMO Open. 2021;6:100118.
    PubMed         Abstract available

  35. ARAUJO-FERNANDEZ I, Delgado J, Moscetti L, Sarac SB, et al
    The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
    ESMO Open. 2021;6:100008.
    PubMed         Abstract available

  36. RUIZ-BANOBRE J, Molina-Diaz A, Fernandez-Calvo O, Fernandez-Nunez N, et al
    Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study.
    ESMO Open. 2021;6:100090.
    PubMed         Abstract available


    Ethiop J Health Sci

  37. BEYENE A
    A Retrospective Analysis of Clinical and Pathologic Characteristics of Recurrent Bladder Tumor in a Tertiary Hospital in Addis Ababa, Ethiopia.
    Ethiop J Health Sci. 2021;31:779-784.
    PubMed         Abstract available


    Eur Urol Focus

  38. LEWICKI P, Arenas-Gallo C, Qiu Y, Venkat S, et al
    Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States.
    Eur Urol Focus. 2021 Oct 25. pii: S2405-4569(21)00271.
    PubMed         Abstract available


    Front Endocrinol (Lausanne)

  39. LU Y, Tao J
    Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Front Endocrinol (Lausanne). 2021;12:699732.
    PubMed         Abstract available

  40. BERNARDO C, Monteiro FL, Direito I, Amado F, et al
    Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance.
    Front Endocrinol (Lausanne). 2021;12:684140.
    PubMed         Abstract available


    Front Genet

  41. XIAO H, Huang W, Li Y, Zhang R, et al
    Targeting Long Non-Coding RNA TTN-AS1 Suppresses Bladder Cancer Progression.
    Front Genet. 2021;12:704712.
    PubMed         Abstract available


    Front Immunol

  42. ZENG D, Ye Z, Shen R, Yu G, et al
    IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Front Immunol. 2021;12:687975.
    PubMed         Abstract available


    Front Oncol

  43. JIANG G, Wang H, Huang D, Wu Y, et al
    The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer.
    Front Oncol. 2021;11:752860.
    PubMed         Abstract available

  44. TONG Y, Liu X, Xia D, Peng E, et al
    Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer.
    Front Oncol. 2021;11:704703.
    PubMed         Abstract available

  45. XIE Z, Cai J, Sun W, Hua S, et al
    Development and Validation of Prognostic Model in Transitional Bladder Cancer Based on Inflammatory Response-Associated Genes.
    Front Oncol. 2021;11:740985.
    PubMed         Abstract available

  46. JIANG X, Xia Y, Meng H, Liu Y, et al
    Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer.
    Front Oncol. 2021;11:746029.
    PubMed         Abstract available


    Future Oncol

  47. GHOSH S, Basu M, Banerjee K, Chaudhury SP, et al
    Arsenic level in bladder tumor of patients from an exposed population: association with progression and prognosis.
    Future Oncol. 2021;17:1311-1323.
    PubMed         Abstract available


    Gene

  48. WANG X, Guo Z, Zhu H, Xin J, et al
    Genetic variants in splicing factor genes and susceptibility to bladder cancer.
    Gene. 2021 Oct 18:146022. doi: 10.1016/j.gene.2021.146022.
    PubMed         Abstract available


    In Vivo

  49. TOMISAKI I, Harada M, Tokutsu K, Minato A, et al
    Impact of C-reactive Protein Flare Response in Patients With Advanced Urothelial Carcinoma Who Received Pembrolizumab.
    In Vivo. 2021;35:3563-3568.
    PubMed         Abstract available


    Int J Clin Oncol

  50. OBAYASHI K, Miki J, Fukuokaya W, Yanagisawa T, et al
    The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
    Int J Clin Oncol. 2021 Oct 29. pii: 10.1007/s10147-021-02059.
    PubMed         Abstract available


    Int J Mol Sci

  51. GILL E, Sandhu G, Ward DG, Perks CM, et al
    The Sirenic Links between Diabetes, Obesity, and Bladder Cancer.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  52. DAHL DM, Rodgers J, Shipley WU, Michaelson D, et al
    NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-St
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available

  53. KOTHA NV, Kumar A, Nelson TJ, Qiao EM, et al
    Factors Associated With Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available

  54. MURALIDHAR V, Carvalho F, Preston M, Curran C, et al
    Genomic Features of Radiation-Associated Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available

  55. KOTHA NV, Kumar A, Nelson TJ, Qiao EM, et al
    Patterns of Failure After Definitive Chemoradiation for Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available

  56. CHEN K, Chauhan PS, Babbra RK, Feng W, et al
    Urine- and Plasma-Based Detection of Minimal Residual Disease in Localized Bladder Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available

  57. VUONG W, Ganguly SY, Balyimez A, Halima A, et al
    Identification of Putative Gene-Target Modulators of Radiosensitivity in Bladder Cancer Cell Lines (BlaCCL).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available

  58. QUILES CG, Mallender R, More E, Humphries J, et al
    Proteomic Profiling of Hypoxia-Induced Changes in Cell-Derived Extracellular Matrix From Bladder Cancer Cell Lines.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed         Abstract available


    J Bras Pneumol

  59. AZEVEDO M, Zanetti G, Marchiori E
    An uncommon cause of miliary disease: intravesical BCG immunotherapy.
    J Bras Pneumol. 2021;47:e20210211.
    PubMed        


    J Cell Mol Med

  60. CHEN W, Zhao S, Yu W, Rao T, et al
    SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/beta-catenin pathway.
    J Cell Mol Med. 2021 Oct 22. doi: 10.1111/jcmm.17005.
    PubMed         Abstract available


    J Endourol

  61. LI P, Zhou H, Cao H, Xu B, et al
    Robot-Assisted Laparoscopic Management of Bladder/Prostate Rhabdomyosarcoma in Children: Initial Series and 1-Year Outcomes.
    J Endourol. 2021;35:1520-1525.
    PubMed         Abstract available

  62. MAZOUIN C, Hubert J, Tricard T, Lecoanet P, et al
    Robot-Assisted Cystectomy and Ileal Conduit for Neurogenic Bladder: Comparison of Extracorporeal vs Intracorporeal Urinary Diversion.
    J Endourol. 2021;35:1350-1356.
    PubMed         Abstract available

  63. JOSEPH JP, O'Malley P, Su LM
    Robot-Assisted Radical Nephroureterectomy.
    J Endourol. 2021;35.
    PubMed         Abstract available

  64. HAM WS, Rha KH, Han WK, Kwon TG, et al
    Oncologic Outcomes of Intracorporeal vs Extracorporeal Urinary Diversion After Robot-Assisted Radical Cystectomy: A Multi-Institutional Korean Study.
    J Endourol. 2021;35:1490-1497.
    PubMed         Abstract available

  65. CHEN AB, Polotti CF, Zhang M, Yip W, et al
    Robotic Intracorporeal Ileal Conduit Urinary Diversion Technique.
    J Endourol. 2021;35.
    PubMed         Abstract available

  66. DEFIDIO L, Antonucci M, Castellani D, Civitella A, et al
    Transurethral Resection of Bladder Tumor: Electrosurgical and Laser.
    J Endourol. 2021;35.
    PubMed         Abstract available

  67. TRUONG H, Maxon V, Goh AC
    Robotic Female Radical Cystectomy.
    J Endourol. 2021;35.
    PubMed         Abstract available


    J Immunol Res

  68. WANG L, Wang Y, Wang J, Li L, et al
    Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
    J Immunol Res. 2021;2021:3236384.
    PubMed         Abstract available


    J Pain Palliat Care Pharmacother

  69. JONES JF, Hirst JM, Edmonds KP, Atayee RS, et al
    A Case Report of Phenobarbital for Proportionate Sedation to Control Refractory Symptoms at the End of Life in an Opioid Tolerant Patient.
    J Pain Palliat Care Pharmacother. 2021;35:167-174.
    PubMed         Abstract available


    J Pathol Clin Res

  70. JACKSON CL, Chen L, Hardy CS, Ren KY, et al
    Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer.
    J Pathol Clin Res. 2021 Oct 26. doi: 10.1002.
    PubMed         Abstract available


    J Robot Surg

  71. IP KL, Javier-DesLoges JF, Leung C, Nie J, et al
    Comparison of long-term outcomes in a 10-year experience of robotic cystectomy vs. open cystectomy.
    J Robot Surg. 2021;15:773-780.
    PubMed         Abstract available


    J Urol

  72. KHALEEL S, Regmi S, Hannah P, Watarai B, et al
    Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy.
    J Urol. 2021;206:1132-1138.
    PubMed         Abstract available

  73. HENSLEY PJ, Bree KK, Campbell MT, Alhalabi O, et al
    Progression of Disease after Bacillus Calmette-Guerin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.
    J Urol. 2021;206:1258-1267.
    PubMed         Abstract available

  74. BREE KK, Navai N
    Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply.
    J Urol. 2021 Oct 25:101097JU0000000000002307. doi: 10.1097/JU.0000000000002307.
    PubMed        

  75. SCHUETTFORT VM, Pradere B, D'Andrea D, Grossmann NC, et al
    Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
    J Urol. 2021;206:1122-1131.
    PubMed         Abstract available

  76. CHAPPIDI MR, Yang H, Meng MV, Bivalacqua TJ, et al
    Utility of Blue Light Cystoscopy for Post-BCG Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons.
    J Urol. 2021 Oct 25:101097JU0000000000002308. doi: 10.1097/JU.0000000000002308.
    PubMed         Abstract available

  77. KHANNA A, Miest T, Sharma V, Campbell R, et al
    Role of Lymphadenectomy During Radical Cystectomy for Non-muscle Invasive Bladder Cancer: Results From a Multi-Institutional Experience.
    J Urol. 2021 Oct 25:101097JU0000000000002266. doi: 10.1097/JU.0000000000002266.
    PubMed         Abstract available

  78. DE LA CALLE CM, Patel SH, Kates M
    Contemporary Rates of Gynecologic Organ Involvement in Females With Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Letter.
    J Urol. 2021 Oct 25:101097JU0000000000002306. doi: 10.1097/JU.0000000000002306.
    PubMed        


    Kaohsiung J Med Sci

  79. WU ZZ, Xu Q
    Bladder cancer-associated transcript 1 promotes melanoma cell proliferation and invasion via the miR-374b-5p/U2-associated factor homology motif kinase 1 axis.
    Kaohsiung J Med Sci. 2021 Oct 28. doi: 10.1002/kjm2.12463.
    PubMed         Abstract available


    Libyan J Med

  80. KHABAZ MN, Qureshi IA, Al-Maghrabi JA
    Leptin expression is substantially correlated with prognosis of urinary bladder carcinoma.
    Libyan J Med. 2021;16:1949798.
    PubMed         Abstract available


    Lipids Health Dis

  81. ZHU K, Xiaoqiang L, Deng W, Wang G, et al
    Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Lipids Health Dis. 2021;20:146.
    PubMed         Abstract available


    Medicina (Kaunas)

  82. SIDDIQUI AJ, Khan MF, Hamadou WS, Goyal M, et al
    Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against Schistosoma-Associated Bladder Cancer Targeting Protein Signaling: Computational Drug Repositioning Approach.
    Medicina (Kaunas). 2021;57.
    PubMed         Abstract available


    Minerva Surg

  83. FENG D, Wang Z, Yang Y, Li A, et al
    Ultrasound-guided technique versus ultrasound with nerve stimulation technique for obturator nerve block in transurethral resection of bladder tumors under spinal anesthesia: a meta-analysis.
    Minerva Surg. 2021;76:192-194.
    PubMed        


    Mol Biol Rep

  84. AY A, Alkanli N, Cevik G
    Investigation of the relationship between MMP-1 (- 1607 1G/2G), MMP-3 (- 1171 5A/6A) gene variations and development of bladder cancer.
    Mol Biol Rep. 2021 Oct 25. pii: 10.1007/s11033-021-06775.
    PubMed         Abstract available


    Mol Clin Oncol

  85. JAIN M, Kamalov D, Tivtikyan A, Balatsky A, et al
    Urine TERT promoter mutations-based tumor DNA detection in patients with bladder cancer: A pilot study.
    Mol Clin Oncol. 2021;15:253.
    PubMed         Abstract available


    Mol Ther Nucleic Acids

  86. CHEN L, Li W, Li Z, Song Y, et al
    circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis.
    Mol Ther Nucleic Acids. 2021;26:625-636.
    PubMed         Abstract available


    Nat Commun

  87. TATE T, Xiang T, Wobker SE, Zhou M, et al
    Pparg signaling controls bladder cancer subtype and immune exclusion.
    Nat Commun. 2021;12:6160.
    PubMed         Abstract available


    PeerJ

  88. YOU C, Li X, Du Y, Wang H, et al
    Application of intra-arterial chemotherapy in high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis.
    PeerJ. 2021;9:e12248.
    PubMed         Abstract available


    Pol J Pathol

  89. KUNC M, Biernat W
    Skene's gland adenocarcinoma coexisting with infiltrating urothelial carcinoma of the urinary bladder.
    Pol J Pathol. 2021;72:170-173.
    PubMed         Abstract available


    S Afr J Surg

  90. PLUKE KD, Kaestner L
    Lessons from a pilot study of screening for upper tract urothelial cell carcinoma in Lynch syndrome.
    S Afr J Surg. 2021;59:65a-65d.
    PubMed         Abstract available


    Scand J Urol

  91. BJORNSSON O, Jonsson E, Guethmundsson EO, Marteinsson VThorn, et al
    Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study.
    Scand J Urol. 2021;55:197-202.
    PubMed         Abstract available


    Sci Rep

  92. BEJRANANDA T, Kanjanapradit K, Saetang J, Sangkhathat S, et al
    Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer.
    Sci Rep. 2021;11:21186.
    PubMed         Abstract available


    Semin Diagn Pathol

  93. SIROHI D MD, Ohe C, Smith SC, Amin MB, et al
    SWI/SNF-deficient neoplasms of the genitourinary tract.
    Semin Diagn Pathol. 2021;38:212-221.
    PubMed         Abstract available


    Surg Pathol Clin

  94. AL-AHMADIE H, Netto GJ
    Molecular Pathology of Urothelial Carcinoma.
    Surg Pathol Clin. 2021;14:403-414.
    PubMed         Abstract available


    Urol Int

  95. WANG Y, Qu H, Xu B, Wu J, et al
    Expression of FOXA1 Is Associated with the Tumor-Infiltrating M2 Macrophage, Cytotoxic T Lymphocyte, and Effect of Chemotherapy in Bladder Cancer.
    Urol Int. 2021 Oct 27:1-6. doi: 10.1159/000519129.
    PubMed         Abstract available


    Urologe A

  96. LEUCHT K, Foller S, Grimm MO
    [Bacillus Calmette-Guerin (BCG) and alternatives : Drug treatment of high-risk non-muscle invasive bladder cancer].
    Urologe A. 2021 Oct 28. pii: 10.1007/s00120-021-01681.
    PubMed         Abstract available


    Vet Pathol

  97. MAEDA S, Yoshitake R, Chambers JK, Uchida K, et al
    BRAF(V595E) Mutation Associates CCL17 Expression and Regulatory T Cell Recruitment in Urothelial Carcinoma of Dogs.
    Vet Pathol. 2021;58:971-980.
    PubMed         Abstract available

  98. AVALLONE G, Rasotto R, Chambers JK, Miller AD, et al
    Review of Histological Grading Systems in Veterinary Medicine.
    Vet Pathol. 2021;58:809-828.
    PubMed         Abstract available


    Zentralbl Chir

  99. BUERGER M, Kapahnke S, Omran S, Muller V, et al
    [Aortic Complications Related to Mycobacterium bovis after Intravesical Bacille Calmette-Guerin Therapy - a Systematic Review].
    Zentralbl Chir. 2021;146:506-520.
    PubMed         Abstract available


    Zhonghua Zhong Liu Za Zhi


  100. [Clinical pathological expert consensus on HER-2 testing in urothelial carcinoma in China].
    Zhonghua Zhong Liu Za Zhi. 2021;43:1001-1006.
    PubMed         Abstract available


  101. [Expert consensus on intravesical therapy for non-muscle invasive bladder cancer (2021 edition)].
    Zhonghua Zhong Liu Za Zhi. 2021;43:1027-1033.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: